Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure

作者: Dale J. Hamilton , Aijun Zhang , Shumin Li , Tram N. Cao , Jessie A. Smith

DOI: 10.1152/AJPHEART.00746.2015

关键词: Nitric oxideOxidative stressBiologyAngiotensin IIMuscle hypertrophyPyruvate dehydrogenase complexInternal medicineMitochondrionRespiratory functionOxidative phosphorylationEndocrinology

摘要: Mitochondrial dysfunction has been implicated as a cause of energy deprivation in heart failure (HF). Herein, we tested individual and combined effects two pathogenic factors nonischemic HF, inhibition nitric oxide synthesis [with l-N(G)-nitroarginine methyl ester (l-NAME)] hypertension angiotensin II (AngII)], on myocardial mitochondrial function, oxidative stress, metabolic gene expression. l-NAME AngII were administered individually combination to mice for 5 wk. Although all treatments increased blood pressure reduced cardiac contractile the + group was associated with most severe characterized by edema, hypertrophy, expression Nppa Nppb, decreased Atp2a2 Camk2b. AngII-treated exhibited robust deterioration observed respiratory control ratios subsarcolemmal mitochondria state 3 levels interfibrillar complex I but not substrates. Cardiac myofibrils showed ADP-supported oligomycin-inhibited oxygen consumption. functional impairment accompanied DNA content activities pyruvate dehydrogenase H2O2 production tissue protein carbonyls hearts from groups. Microarray analyses revealed majority changes attributed group. Pathway indicated significant pathways, such phosphorylation, fatty acid metabolism hearts. We conclude that is impaired function stress compared either or alone, resulting HF.

参考文章(46)
F Follath, Ischemic versus non-ischemic heart failure: should the etiology be determined? Heart failure monitor. ,vol. 1, pp. 122- 125 ,(2001)
Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Aries, Pierre Paradis, Mechanisms of angiotensin II-dependent progression to heart failure. Novartis Foundation symposium. ,vol. 274, pp. 58- 72 ,(2006) , 10.1002/0470029331.CH5
Jo Vandesompele, Katleen De Preter, Filip Pattyn, Bruce Poppe, Nadine Van Roy, Anne De Paepe, Frank Speleman, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biology. ,vol. 3, pp. 1- 12 ,(2002) , 10.1186/GB-2002-3-7-RESEARCH0034
Bert R. Everaert, Gaëlle A. Boulet, Jean-Pierre Timmermans, Christiaan J. Vrints, Importance of Suitable Reference Gene Selection for Quantitative Real-Time PCR: Special Reference to Mouse Myocardial Infarction Studies PLoS ONE. ,vol. 6, pp. e23793- ,(2011) , 10.1371/JOURNAL.PONE.0023793
J. George, A. D. Struthers, C. C. Lang, Modulation of the renin-angiotensin-aldosterone system in heart failure. Current Atherosclerosis Reports. ,vol. 16, pp. 403- ,(2014) , 10.1007/S11883-014-0403-7
David M. Roth, James S. Swaney, Nancy D. Dalton, Elizabeth A. Gilpin, John Ross, Impact of anesthesia on cardiac function during echocardiography in mice American Journal of Physiology-heart and Circulatory Physiology. ,vol. 282, ,(2002) , 10.1152/AJPHEART.00845.2001
Daniela Zablocki, Junichi Sadoshima, Angiotensin II and oxidative stress in the failing heart. Antioxidants & Redox Signaling. ,vol. 19, pp. 1095- 1109 ,(2013) , 10.1089/ARS.2012.4588
B Dahlöf, Left ventricular hypertrophy and angiotensin II antagonists. American Journal of Hypertension. ,vol. 14, pp. 174- 182 ,(2001) , 10.1016/S0895-7061(00)01257-7
Hélène Lemieux, Severin Semsroth, Herwig Antretter, Daniel Höfer, Erich Gnaiger, Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart The International Journal of Biochemistry & Cell Biology. ,vol. 43, pp. 1729- 1738 ,(2011) , 10.1016/J.BIOCEL.2011.08.008